These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 498717)

  • 1. Changes in calcium excretion after prolonged metolazone therapy in recurrent stone formers.
    Lespier-Dexter LE; Martinez-Maldonado M
    Clin Pharmacol Ther; 1979 Dec; 26(6):752-6. PubMed ID: 498717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metolazone therapy of active calcium nephrolithiasis.
    Cunningham E; Oliveros FH; Nascimento L
    Clin Pharmacol Ther; 1982 Nov; 32(5):642-5. PubMed ID: 7128005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calciuric response to an acute acid load in healthy subjects and hypercalciuric calcium stone formers.
    Houillier P; Normand M; Froissart M; Blanchard A; Jungers P; Paillard M
    Kidney Int; 1996 Sep; 50(3):987-97. PubMed ID: 8872975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E; Schmidt-Gayk H; Möhring K
    Eur Urol; 1975; 1(3):131-3. PubMed ID: 183957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B; Lippuner K; Takkinen R; Villiger L; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1995; 10(9):1614-9. PubMed ID: 8559479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnesium excretion in recurrent calcium urolithiasis].
    Pfab R; Hegemann M; Schütz W; Böttger I
    Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia.
    Segar JL; Robillard JE; Johnson KJ; Bell EF; Chemtob S
    J Pediatr; 1992 Jun; 120(6):966-73. PubMed ID: 1593359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure.
    Steuber TD; Janzen KM; Howard ML
    Pharmacotherapy; 2020 Sep; 40(9):924-935. PubMed ID: 32639593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of urinary calcium excretion after oral calcium load in stone formers, their spouses and first-degree blood relatives.
    Kaul P; Sidhu H; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1994; 52(2):93-7. PubMed ID: 8178384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone.
    Cardinale M; Altshuler J; Testani JM
    Pharmacotherapy; 2016 Aug; 36(8):843-51. PubMed ID: 27321568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic hypercalciuria: hydrochlorothiazide decrease urinary calcium without altered renal response to parathyroid hormone.
    Van Den Berg CJ; Tucker RM; Dousa TP
    J Clin Endocrinol Metab; 1982 Jul; 55(1):23-6. PubMed ID: 6281301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal handling of sodium and calcium in hypercalciuria.
    Nascimento L; Oliveros FH; Cunningham E
    Clin Pharmacol Ther; 1984 Mar; 35(3):342-7. PubMed ID: 6697641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR; Kane RE
    J Clin Pharmacol; 1977 Apr; 17(4):243-51. PubMed ID: 849998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D; Ravery V; Boccon-Gibod L; Friedlander G
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.